Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization

Journal of Clinical Investigation

Volumn 120, Issue 6, 2010, Pages 1981-1993

  Ito, Yuji ^a   Teitelbaum, Steven L ^a   Zou, Wei ^a   Zheng, Yi ^a   Johnson, James F ^b   Chappel, Jean ^a   Ross, F Patrick ^a   Zhao, Haibo ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CASPASE 3; COLONY STIMULATING FACTOR 1; CYCLIN D; GUANOSINE TRIPHOSPHATASE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN CDC42; RETINOBLASTOMA PROTEIN;

ALBERS SCHOENBERG DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE REMODELING; CELL DIFFERENTIATION; CELL LINEAGE; CELL POLARITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INACTIVATION; FEMALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; BONE AND BONES; BONE RESORPTION; CASPASE 3; CELL DIFFERENTIATION; CYCLIN D1; CYTOSKELETON; FEMALE; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, KNOCKOUT; OSTEOCLASTS; PHOSPHORYLATION; RANK LIGAND; SIGNAL TRANSDUCTION;

EID: 77953181212     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI39650     Document Type: Article

References (54)

1. Zaidi M. Skeletal remodeling in health and disease. Nat Med. 2007;13(7):791-801.
2. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337-342.
3. Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003;4(8):638-649. (Pubitemid 36917505)
4. Vaananen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J Cell Sci. 2000;113(Pt 3):377-381.
5. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol. 2005;21:247-269.
6. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans. 2005;33(Pt 5):891-895.
7. Chellaiah MA. Regulation of actin ring formation by rho GTPases in osteoclasts. J Biol Chem. 2005;280(38):32930-32943.
8. Fukuda A, et al. Regulation of Osteoclast Apoptosis and Motility by Small GTPase Binding Protein Rac1. J Bone Miner Res. 2005;20(12):2245-2253. (Pubitemid 41698787)
9. Zhang D, et al. The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts. J Cell Sci. 1995;108(Pt 6):2285-2292.
10. Chellaiah MA, et al. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem. 2000;275(16):11993- 12002.
11. Destaing O, et al. A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts. J Cell Sci. 2005;118(Pt 13):2901-2911. (Pubitemid 41136367)
12. Faccio R, et al. Vav3 regulates osteoclast function and bone mass. Nat Med. 2005;11(3):284-290. (Pubitemid 40460556)
13. Calle Y, et al. WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood. 2004;103(9):3552-3561. (Pubitemid 38525693)
14. Hurst IR, Zuo J, Jiang J, Holliday LS. Actin-related protein 2/3 complex is required for actin ring formation. J Bone Miner Res. 2004;19(3):499-506. (Pubitemid 38787406)
15. Kim H, et al. Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J Clin Invest. 2009;119(4):813-825.
16. Yang L, Wang L, Zheng Y. Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts. Mol Biol Cell. 2006;17(11):4675-4685. (Pubitemid 44665738)
17. Nakamura T, et al. Estrogen prevents bone loss via estrogen receptor ? and induction of Fas ligand in osteoclasts. Cell. 2007;130(5):811-823. (Pubitemid 47332572)
18. Wang L, Yang L, Burns K, Kuan CY, Zheng Y. Cdc-42GAP regulates c-Jun N-terminal kinase (JNK)-mediated apoptosis and cell number during mammalian perinatal growth. Proc Natl Acad Sci U S A. 2005;102(38):13484-13489. (Pubitemid 41420874)
19. Bai S, et al. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J Biol Chem. 2008;283(10):6509-6518.
20. Barfod ET, et al. Cloning and expression of a human CDC42 GTPase-activating protein reveals a functional SH3-binding domain. J Biol Chem. 1993;268(35):26059-26062.
21. Zhou P, Kitaura H, Teitelbaum SL, Krystal G, Ross FP, Takeshita S. SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cyclins and p27. J Immunol 2006;177(12):8777-8784. (Pubitemid 44893844)
22. Fesik SW. Insights into programmed cell death through structural biology. Cell. 2000; 103(2):273-282.
23. Akiyama T, et al. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 2003;22(24):6653-6664. (Pubitemid 38009611)
24. Mansky KC, Sankar U, Han J, Ostrowski MC. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling. J Biol Chem. 2002;277(13):11077-11083. (Pubitemid 34952867)
25. Tapon N, Hall A. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol. 1997;9(1):86-92. (Pubitemid 27065113)
26. Jurdic P, Saltel F, Chabadel A, Destaing O. Podosome and sealing zone: specificity of the osteoclast model. Eur J Cell Biol. 2006;85(3-4):195-202.
27. Kim HJ, et al. Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest. 2006;116(8):2152-2160. (Pubitemid 44162324)
28. Lin D, Edwards AS, Fawcett JP, Mbamalu G, Scott JD, Pawson T. A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signalling and cell polarity. Nat Cell Biol. 2000;2(8):540-547.
29. Joberty G, Petersen C, Gao L, Macara IG. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol. 2000;2(8):531-539.
30. Yamanaka T, et al. Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity. Curr Biol. 2003;13(9):734-743. (Pubitemid 36531020)
31. Plant PJ, et al. A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nat Cell Biol. 2003;5(4):301-308.
32. Suzuki A, Ohno S. The PAR-aPKC system: lessons in polarity. J Cell Sci. 2006;119(Pt 6):979-987.
33. Suzuki A, Akimoto K, Ohno S. Protein kinase C λ/ι (PKCλ/ι): a PKC isotype essential for the development of multicellular organisms. J Biochem. 2003;133(1):9-16. (Pubitemid 36240973)
34. Hirai T, Chida K. Protein kinase Cζ (PKCζ): activation mechanisms and cellular functions. J Biochem. 2003;133(1):1-7. (Pubitemid 36240972)
35. Erickson JW, Cerione RA. Multiple roles for Cdc42 in cell regulation. Curr Opin Cell Biol. 2001;13(2):153-157.
36. Krum SA, et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 2008;27(3):535-545.
37. Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM. Osteoclast apoptosis: the role of Fas in vivo and in vitro. Endocrinology. 2003;144(12):5545-5555. (Pubitemid 37476084)
38. Zhao H, Ross FP, Teitelbaum SL. Unoccupied αvβ3 integrin regulates osteoclast apoptosis by transmitting a positive death signal. Mol Endocrinol. 2005;19(3):771-780. (Pubitemid 40349447)
39. Gnesutta N, Qu J, Minden A. The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J Biol Chem. 2001;276(17):14414-14419. (Pubitemid 37391833)
40. Bradley EW, Ruan MM, Oursler MJ. PAK1 is a novel MEK-independent raf target controlling expression of the IAP survivin in M-CSF-mediated osteoclast survival. J Cell Physiol. 2008;217(3):752-758.
41. Sharma SM, et al. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J Biol Chem. 2007;282(21):15921-15929.
42. Lee ZH, Kim HH. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun. 2003;305(2):211-214. (Pubitemid 36555454)
43. Ikeda F, et al. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest. 2004;114(4):475-484. (Pubitemid 39572097)
44. Saltel F, Chabadel A, Bonnelye E, Jurdic P. Actin cytoskeletal organisation in osteoclasts: a model to decipher transmigration and matrix degradation. Eur J Cell Biol. 2008;87(8-9):459-468.
45. Saltel F, Destaing O, Bard F, Eichert D, Jurdic P. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol Biol Cell. 2004;15(12):5231-5241. (Pubitemid 39564720)
46. Miki H, Takenawa T. Regulation of actin dynamics by WASP family proteins. J Biochem. 2003;134(3):309-313. (Pubitemid 37288327)
47. Stradal TE, Scita G. Protein complexes regulating Arp2/3-mediated actin assembly. Curr Opin Cell Biol. 2006;18(1):4-10. (Pubitemid 43107601)
48. Millard TH, Sharp SJ, Machesky LM. Signalling to actin assembly via the WASP (Wiskott-Aldrich syndrome protein)-family proteins and the Arp2/3 complex. Biochem J. 2004;380(Pt 1):1-17.
49. Ory S, Brazier H, Blangy A. Identification of a bipartite focal adhesion localization signal in RhoU/Wrch-1, a Rho family GTPase that regulates cell adhesion and migration. Biol Cell. 2007;99(12):701-716. (Pubitemid 350201920)
50. Wang L, Yang L, Filippi MD, Williams DA, Zheng Y. Genetic deletion of Cdc42GAP reveals a role of Cdc42 in erythropoiesis and hematopoietic stem/ progenitor cell survival, adhesion, and engraftment. Blood. 2006;107(1):98-105. (Pubitemid 43053529)
51. Zhao H, Kitaura H, Sands MS, Ross FP, Teitelbaum SL, Novack DV. Critical role of beta3 integrin in experimental postmenopausal osteoporosis. J Bone Miner Res. 2005;20(12):2116-2123. (Pubitemid 41698775)
52. Zhao H, Ito Y, Chappel J, Andrews NW, Teitelbaum SL, Ross FP. Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion. Dev Cell. 2008;14(6):914-925. (Pubitemid 351757201)
53. Takeshita S, Kaji K, Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res. 2000;15(8):1477-1488. (Pubitemid 30484517)
54. Takeshita S, et al. c-Fms tyrosine 559 is a major mediator of M-CSF-induced proliferation of primary macrophages. J Biol Chem. 2007;282(26):18980-18990. (Pubitemid 47100186)